Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

RECRUITING

Triage Survey for Cardiovascular, Obesity, and Related Endocrine Trial Eligibility

NCT06412536 · View on ClinicalTrials.gov ↗

Study Summary

SWIFT-CORE-101 is a single site survey study designed to assess potential participants' eligibility to screen for industry-sponsored clinical trials. A physician will oversee the informed consent process, after which participants will be surveyed on demographics, medical history, comorbidities, and current symptoms. Site staff may collect vital signs, urine drug screens, blood draws, and urine pregnancy tests. A doctor will review medical history with the participant to determine study suitability via clinical interview. The doctor may reach out to the patient's current treating physicians and pharmacies to determine eligibility for clinical trials.

Interventions

  • OTHER Blood work

Study Locations (1)

New York

  • Brooklyn Clinical Research — Brooklyn

Trial Details

FieldValue
Enrollment Target 10,000 participants
Start Date 2024-05-30
Est. Completion 2029-04-17

Sponsor

Brooklyn Clinical Research

2 total trials

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06412536

The ClinicalTrials.gov registry entry for NCT06412536 describes a study currently listed as recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brooklyn Clinical Research, which has 2 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 5 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention — of which Blood work is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT06412536 reports 1 study location spanning 1 distinct geographic area — top geographies include New York. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT06412536 about?

NCT06412536 is a clinical study titled "Triage Survey for Cardiovascular, Obesity, and Related Endocrine Trial Eligibility". SWIFT-CORE-101 is a single site survey study designed to assess potential participants' eligibility to screen for industry-sponsored clinical trials. A physician will oversee the informed consent process, after which participants will be surveyed on demographics, medical history, comorbidities, and ...

What is the current status of trial NCT06412536?

This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2024-05-30. Estimated completion is 2029-04-17.

What conditions does trial NCT06412536 study?

This clinical trial studies the following conditions: Obesity, Cardiovascular Diseases, Metabolic Syndrome, PreDiabetes, Diabetes Type 2. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT06412536?

The interventions under investigation include: Blood work (OTHER). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT06412536?

This trial is sponsored by Brooklyn Clinical Research, which has 2 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT06412536 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial